BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 8389256)

  • 21. The point mutation of p53 gene exon7 in hepatocellular carcinoma from Anhui Province, a non HCC prevalent area in China.
    Liu H; Wang Y; Zhou Q; Gui SY; Li X
    World J Gastroenterol; 2002 Jun; 8(3):480-2. PubMed ID: 12046074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis B, aflatoxin B(1), and p53 codon 249 mutation in hepatocellular carcinomas from Guangxi, People's Republic of China, and a meta-analysis of existing studies.
    Stern MC; Umbach DM; Yu MC; London SJ; Zhang ZQ; Taylor JA
    Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):617-25. PubMed ID: 11401911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aflatoxin and p53 abnormality in duck hepatocellular carcinoma.
    Imazeki F; Yokosuka O; Ohto M; Omata M
    J Gastroenterol Hepatol; 1995; 10(6):646-9. PubMed ID: 8580407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microsatellite instability and p53 mutations in hepatocellular carcinoma.
    Karachristos A; Liloglou T; Field JK; Deligiorgi E; Kouskouni E; Spandidos DA
    Mol Cell Biol Res Commun; 1999; 2(3):155-61. PubMed ID: 10662591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic aflatoxin B1-DNA adducts and TP53 mutations in patients with hepatocellular carcinoma despite low exposure to aflatoxin B1 in southern Japan.
    Shirabe K; Toshima T; Taketomi A; Taguchi K; Yoshizumi T; Uchiyama H; Harimoto N; Kajiyama K; Egashira A; Maehara Y
    Liver Int; 2011 Oct; 31(9):1366-72. PubMed ID: 21745313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China.
    Fujimoto Y; Hampton LL; Wirth PJ; Wang NJ; Xie JP; Thorgeirsson SS
    Cancer Res; 1994 Jan; 54(1):281-5. PubMed ID: 7903205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Relationship between mutation of tumor suppressor gene p53 and development of hepatocellular carcinoma].
    Zhu MH
    Zhonghua Zhong Liu Za Zhi; 1993 Jul; 15(4):245-7. PubMed ID: 7909744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p53 overexpression is frequent in European hepatocellular carcinoma and largely independent of the codon 249 hot spot mutation.
    Volkmann M; Hofmann WJ; Müller M; Räth U; Otto G; Zentgraf H; Galle PR
    Oncogene; 1994 Jan; 9(1):195-204. PubMed ID: 8302580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p53 gene abnormalities are closely related to hepatoviral infections and occur at a late stage of hepatocarcinogenesis.
    Teramoto T; Satonaka K; Kitazawa S; Fujimori T; Hayashi K; Maeda S
    Cancer Res; 1994 Jan; 54(1):231-5. PubMed ID: 8261444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutations of the p53 tumor suppressor gene and ras oncogenes in aflatoxin hepatocarcinogenesis.
    Shen HM; Ong CN
    Mutat Res; 1996 Oct; 366(1):23-44. PubMed ID: 8921985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutational hotspot in the p53 gene in human hepatocellular carcinomas.
    Hsu IC; Metcalf RA; Sun T; Welsh JA; Wang NJ; Harris CC
    Nature; 1991 Apr; 350(6317):427-8. PubMed ID: 1849234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The mutation of codon 249 in the p53 gene is not specific in Japanese hepatocellular carcinoma.
    Hayashi H; Sugio K; Matsumata T; Adachi E; Urata K; Tanaka S; Sugimachi K
    Liver; 1993 Oct; 13(5):279-81. PubMed ID: 8259041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Relationship between mutation on precore region of integrated HBV DNA and p53 gene mutation in hepatocellular carcinoma].
    Wang XH; Wang PL
    Ai Zheng; 2003 Jul; 22(7):715-8. PubMed ID: 12866962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does aflatoxin B1 play a role in the etiology of hepatocellular carcinoma in the United States?
    Hoque A; Patt YZ; Yoffe B; Groopman JD; Greenblatt MS; Zhang YJ; Santella RM
    Nutr Cancer; 1999; 35(1):27-33. PubMed ID: 10624703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Universal presence of HBVx gene and its close association with hotspot mutation of p53 gene in hepatocellular carcinoma of prevalent area in China].
    Zhang F; Zhu Y; Sun Z
    Zhonghua Zhong Liu Za Zhi; 1998 Jan; 20(1):18-21. PubMed ID: 10921048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Characteristics of high frequency 249 codon mutation of p53 gene in hepatocellular carcinoma in prevalent area of China].
    Ming L; Yuan B; Thorgeirsson SS
    Zhonghua Zhong Liu Za Zhi; 1999 Mar; 21(2):122-4. PubMed ID: 11776852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis B 1762T/1764A mutations, hepatitis C infection, and codon 249 p53 mutations in hepatocellular carcinomas from Thailand.
    Kuang SY; Lekawanvijit S; Maneekarn N; Thongsawat S; Brodovicz K; Nelson K; Groopman JD
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):380-4. PubMed ID: 15734961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p53 mutations cluster at codon 249 in hepatitis B virus-positive hepatocellular carcinomas from China.
    Scorsone KA; Zhou YZ; Butel JS; Slagle BL
    Cancer Res; 1992 Mar; 52(6):1635-8. PubMed ID: 1311638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutations at codon 249 of p53 gene in human hepatocellular carcinomas from Tongan, China.
    Yang M; Zhou H; Kong RY; Fong WF; Ren LQ; Liao XH; Wang Y; Zhuang W; Yang S
    Mutat Res; 1997 Nov; 381(1):25-9. PubMed ID: 9403027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.